What is the share price of GPT Healthcare Ltd (GPTHEALTH) today?
The share price of GPTHEALTH as on 5th December 2025 is ₹143.08. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on GPT Healthcare Ltd (GPTHEALTH) share?
The past returns of GPT Healthcare Ltd (GPTHEALTH) share are- Past 1 week: -1.36%
- Past 1 month: -4.58%
- Past 3 months: -6.95%
- Past 6 months: -4.67%
- Past 1 year: -23.18%
- Past 3 years: N/A%
- Past 5 years: -28.71%
What are the peers or stocks similar to GPT Healthcare Ltd (GPTHEALTH)?
The peers or stocks similar to GPT Healthcare Ltd (GPTHEALTH) include:What is the dividend yield % of GPT Healthcare Ltd (GPTHEALTH) share?
The current dividend yield of GPT Healthcare Ltd (GPTHEALTH) is 1.75.What is the market cap of GPT Healthcare Ltd (GPTHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of GPT Healthcare Ltd (GPTHEALTH) is ₹1174.04 Cr as of 5th December 2025.What is the 52 week high and low of GPT Healthcare Ltd (GPTHEALTH) share?
The 52-week high of GPT Healthcare Ltd (GPTHEALTH) is ₹192 and the 52-week low is ₹126.10.What is the PE and PB ratio of GPT Healthcare Ltd (GPTHEALTH) stock?
The P/E (price-to-earnings) ratio of GPT Healthcare Ltd (GPTHEALTH) is 23.52. The P/B (price-to-book) ratio is 4.74.Which sector does GPT Healthcare Ltd (GPTHEALTH) belong to?
GPT Healthcare Ltd (GPTHEALTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy GPT Healthcare Ltd (GPTHEALTH) shares?
You can directly buy GPT Healthcare Ltd (GPTHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
GPT Healthcare Ltd
GPTHEALTH Share Price
143.081.48% (+2.08)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GPTHEALTH Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GPTHEALTH Performance & Key Metrics
GPTHEALTH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 27.03 | 4.74 | 1.75% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.87 | 5.82 | 0.59% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
GPTHEALTH Company Profile
GPT Healthcare is engaged in the operation of multidisciplinary private hospitals and pharmacies.
MAXHEALTH
PE Ratio
99.22
99.22
1Y Return
0.05%
0.05%
Buy Reco %
77.27
77.27
APOLLOHOSP
PE Ratio
71.49
71.49
1Y Return
1.17%
1.17%
Buy Reco %
86.21
86.21
FORTIS
PE Ratio
86.64
86.64
1Y Return
28.04%
28.04%
Buy Reco %
75.00
75.00
PE Ratio
49.27
49.27
1Y Return
46.26%
46.26%
Buy Reco %
77.78
77.78
ASTERDM
PE Ratio
6.10
6.10
1Y Return
29.94%
29.94%
Buy Reco %
100.00
100.00
GPTHEALTH Sentiment Analysis
GPTHEALTH Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
GPTHEALTH Stock Summary · November 2025
GPT Healthcare Limited is strategically expanding its footprint in eastern India, with plans for a new 150-bed hospital in Jamshedpur, aimed at enhancing healthcare access in underserved regions. Despite reporting a year-on-year revenue growth of 12.5%, the company faces challenges, including a 10% decline in EBITDA due to initial losses from new facilities like the underperforming Raipur hospital. Management remains optimistic about future growth, projecting a 15% overall increase as operational efficiencies improve and occupancy rates rise. The company is committed to an asset-light model while exploring both acquisition and greenfield opportunities to navigate the competitive landscape and optimize patient care.
GPTHEALTH Stock Growth Drivers
GPTHEALTH Stock Growth Drivers
6Expansion of Healthcare Facilities
The company has signed a Memorandum of Understanding (MOU) for a new 150-bed hospital in
Financial Performance and Growth
In Q2 FY '26, the company reported revenue from operations of INR 118.9 crores, reflecting
GPTHEALTH Stock Challenges
GPTHEALTH Stock Challenges
4Financial Losses
The company has reported significant financial losses, with a Q2 loss of approximately INR 3
Project Delays
There are ongoing procedural delays affecting the Ranchi project, which is still awaiting necessary government
GPTHEALTH Forecast
GPTHEALTH Forecasts
Price
Revenue
Earnings
GPTHEALTH Share Price Forecast
GPTHEALTH Share Price Forecast
2025
Current
₹143.08
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹143.08
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
GPTHEALTH Company Revenue Forecast
GPTHEALTH Company Revenue Forecast
2025
Current
₹415.58
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹415.58
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
GPTHEALTH Stock EPS (Earnings Per Share) Forecast
GPTHEALTH Stock EPS (Earnings Per Share) Forecast
2025
Current
₹6.08
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹6.08
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
GPTHEALTH
GPTHEALTH
Income
Balance Sheet
Cash Flow
Annual Normal View
GPTHEALTH Income Statement
GPTHEALTH Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 216.07 | 248.86 | 342.40 | 366.73 | 405.48 | 415.58 | 435.99 | |||||||
Raw Materials | 38.41 | 57.27 | 87.38 | 75.86 | 82.96 | 78.79 | 347.56 | |||||||
| Power & Fuel Cost | 6.19 | 6.80 | 7.42 | 8.08 | 9.53 | 9.49 | ||||||||
| Employee Cost | 42.04 | 41.66 | 53.78 | 62.04 | 68.93 | 73.02 | ||||||||
| Selling & Administrative Expenses | 19.04 | 22.49 | 9.36 | 12.92 | 11.84 | 17.69 | ||||||||
| Operating & Other expenses | 70.36 | 65.54 | 105.64 | 127.78 | 139.09 | 144.75 | ||||||||
EBITDA | 40.03 | 55.10 | 78.82 | 80.05 | 93.13 | 91.84 | 88.43 | |||||||
| Depreciation/Amortization | 11.08 | 12.47 | 13.59 | 14.91 | 17.98 | 19.03 | 22.58 | |||||||
| PBIT | 28.95 | 42.63 | 65.23 | 65.14 | 75.15 | 72.81 | 65.85 | |||||||
| Interest & Other Items | 14.12 | 13.75 | 11.15 | 9.16 | 7.11 | 3.47 | 5.66 | |||||||
| PBT | 14.83 | 28.88 | 54.08 | 55.98 | 68.04 | 69.34 | 60.19 | |||||||
| Taxes & Other Items | 3.88 | 7.79 | 12.41 | 16.96 | 20.27 | 19.43 | 16.75 | |||||||
| Net Income | 10.95 | 21.09 | 41.67 | 39.02 | 47.77 | 49.91 | 43.44 | |||||||
| EPS | 2.03 | 3.92 | 6.23 | 4.88 | 5.90 | 6.08 | 5.29 | |||||||
| DPS | 0.00 | 1.83 | 0.00 | 5.00 | 3.50 | 2.50 | 2.50 | |||||||
| Payout ratio | 0.00 | 0.47 | 0.00 | 1.02 | 0.59 | 0.41 | 0.47 |
GPTHEALTH Company Updates
FY 2026FY 2026
Investor Presentation
Nov 8PDF
Aug 6PDF
GPTHEALTH Stock Peers
GPTHEALTH Past Performance & Peer Comparison
GPTHEALTH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| GPT Healthcare Ltd | 23.52 | 4.74 | 1.75% |
| Max Healthcare Institute Ltd | 99.22 | 11.38 | 0.14% |
| Apollo Hospitals Enterprise Ltd | 71.49 | 9.31 | 0.18% |
| Fortis Healthcare Ltd | 86.64 | 7.32 | 0.11% |
GPTHEALTH Stock Price Comparison
Compare GPTHEALTH with any stock or ETFCompare GPTHEALTH with any stock or ETF
GPTHEALTH
GPTHEALTH Holdings
GPTHEALTH Shareholdings
GPTHEALTH Promoter Holdings Trend
GPTHEALTH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
GPTHEALTH Institutional Holdings Trend
GPTHEALTH Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.54%
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 1.75%
GPTHEALTH Shareholding Pattern
GPTHEALTH Shareholding Pattern
GPTHEALTH Shareholding History
GPTHEALTH Shareholding History
Foreign Institutions
Mutual Funds Invested in GPTHEALTH
Mutual Funds Invested in GPTHEALTH
No mutual funds holding trends are available
Top 5 Mutual Funds holding GPT Healthcare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.1022% | Percentage of the fund’s portfolio invested in the stock 0.28% | Change in the portfolio weight of the stock over the last 3 months 0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 66/242 (+18) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7792% | Percentage of the fund’s portfolio invested in the stock 0.56% | Change in the portfolio weight of the stock over the last 3 months -0.22% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 63/74 (-4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.03% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 112/124 (-12) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing GPTHEALTH stock
smallcases containing GPTHEALTH stock
Looks like this stock is not in any smallcase yet.
GPTHEALTH Events
GPTHEALTH Events
GPTHEALTH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GPTHEALTH Dividend Trend
No dividend trend available
GPTHEALTH Upcoming Dividends
GPTHEALTH Upcoming Dividends
No upcoming dividends are available
GPTHEALTH Past Dividends
GPTHEALTH Past Dividends
Cash Dividend
Ex DateEx DateNov 14, 2025
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 14, 2025
Cash Dividend
Ex DateEx DateJul 29, 2025
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 29, 2025
Cash Dividend
Ex DateEx DateNov 28, 2024
Interim 1
Interim 1 | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 28, 2024
Cash Dividend
Ex DateEx DateJul 18, 2024
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 18, 2024
Cash Dividend
Ex DateEx DateApr 2, 2024
Interim 2
Interim 2 | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Apr 2, 2024
GPTHEALTH Stock News & Opinions
GPTHEALTH Stock News & Opinions
Articles & Videos
Corporate
Board of GPT Healthcare recommends interim dividend
GPT Healthcare announced that the Board of Directors of the Company at its meeting held on 8 November 2025, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Earnings
GPT Healthcare standalone net profit declines 28.48% in the September 2025 quarter
Net profit of GPT Healthcare declined 28.48% to Rs 10.60 crore in the quarter ended September 2025 as against Rs 14.82 crore during the previous quarter ended September 2024. Sales rose 12.54% to Rs 118.91 crore in the quarter ended September 2025 as against Rs 105.66 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales118.91105.66 13 OPM %19.1222.17 - PBDT21.9225.49 -14 PBT15.0720.69 -27 NP10.6014.82 -28 Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
GPT Healthcare to discuss results
GPT Healthcare will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
GPT Healthcare standalone net profit declines 22.89% in the June 2025 quarter
Net profit of GPT Healthcare declined 22.89% to Rs 7.68 crore in the quarter ended June 2025 as against Rs 9.96 crore during the previous quarter ended June 2024. Sales rose 9.50% to Rs 107.11 crore in the quarter ended June 2025 as against Rs 97.82 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales107.1197.82 9 OPM %16.2118.36 - PBDT17.2919.34 -11 PBT11.1114.66 -24 NP7.689.96 -23 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
GPT Healthcare schedules board meeting
GPT Healthcare will hold a meeting of the Board of Directors of the Company on 6 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
GPT Healthcare schedules AGM
GPT Healthcare announced that the 36th Annual General Meeting(AGM) of the company will be held on 5 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of GPT Healthcare recommends final dividend
GPT Healthcare announced that the Board of Directors of the Company at its meeting held on 23 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
GPT Healthcare standalone net profit rises 0.55% in the March 2025 quarter
Net profit of GPT Healthcare rose 0.55% to Rs 12.89 crore in the quarter ended March 2025 as against Rs 12.82 crore during the previous quarter ended March 2024. Sales rose 1.98% to Rs 101.40 crore in the quarter ended March 2025 as against Rs 99.43 crore during the previous quarter ended March 2024. For the full year,net profit rose 4.50% to Rs 49.92 crore in the year ended March 2025 as against Rs 47.77 crore during the previous year ended March 2024. Sales rose 1.72% to Rs 407.09 crore in the year ended March 2025 as against Rs 400.19 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales101.4099.43 2 407.09400.19 2 OPM %20.4123.31 -20.4821.95 - PBDT21.2523.18 -8 88.3886.02 3 PBT16.3718.42 -11 69.3568.04 2 NP12.8912.82 1 49.9247.77 5 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
GPT Healthcare to convene board meeting
GPT Healthcare will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
GPT Healthcare standalone net profit rises 6.80% in the December 2024 quarter
Net profit of GPT Healthcare rose 6.80% to Rs 12.25 crore in the quarter ended December 2024 as against Rs 11.47 crore during the previous quarter ended December 2023. Sales rose 5.82% to Rs 102.21 crore in the quarter ended December 2024 as against Rs 96.59 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales102.2196.59 6 OPM %20.8021.74 - PBDT22.2920.49 9 PBT17.6215.99 10 NP12.2511.47 7 Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 13.98%, vs industry avg of 13.4%
Over the last 5 years, market share stayed at 0.52%
Over the last 5 years, net income has grown at a yearly rate of 35.44%, vs industry avg of 42.46%